MDPHP is believed to act primarily like a strong norepinephrine-dopamine reuptake inhibitor (NDRI). Minimized re-uptake of norepinephrine and dopamine leads to greater concentrations of The 2 catecholamine neurotransmitters from the synaptic cleft, or gap between neurons. The result of this inhibiti